Macquarie Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-761,305
Closed -$7.56M 1036
2025
Q3
$7.56M Sell
761,305
-3,764
-0.5% -$39.2K 0.01% 865
2025
Q2
$7.59M Sell
765,069
-2,374
-0.3% -$25K 0.01% 873
2025
Q1
$9.95M Sell
767,443
-4,565
-0.6% -$60.4K 0.01% 807
2024
Q4
$9.86M Sell
772,008
-2,605
-0.3% -$31.5K 0.01% 805
2024
Q3
$8.63M Buy
774,613
+34,933
+5% +$385K 0.01% 845
2024
Q2
$8.31M Sell
739,680
-198
-0% -$2.31K 0.01% 850
2024
Q1
$9.18M Sell
739,878
-41,683
-5% -$544K 0.01% 848
2023
Q4
$10.9M Sell
781,561
-126,143
-14% -$1.75M 0.01% 804
2023
Q3
$13.4M Buy
907,704
+24,058
+3% +$338K 0.02% 724
2023
Q2
$11.4M Buy
883,646
+123,646
+16% +$1.41M 0.01% 757
2023
Q1
$7.46M Hold
760,000
0.01% 860
2022
Q4
$8.09M Sell
760,000
-1,006
-0.1% -$11.7K 0.01% 877
2022
Q3
$7.96M Sell
761,006
-1,844
-0.2% -$24K 0.01% 884
2022
Q2
$9.6M Hold
762,850
0.01% 874
2022
Q1
$8.27K Hold
762,850
0.01% 975
2021
Q4
$10.7M Hold
762,850
0.01% 916
2021
Q3
$14.7M Hold
762,850
0.01% 842
2021
Q2
$7.51M Hold
762,850
0.01% 1012
2021
Q1
$7.5M Sell
762,850
-874
-0.1% -$7.21K 0.01% 806
2020
Q4
$3.4M Hold
763,724
0.01% 957
2020
Q3
$3.3M Hold
763,724
0.01% 917
2020
Q2
$6.77M Buy
763,724
+3,724
+0.5% +$18.8K 0.01% 723
2020
Q1
$2.68M Hold
760,000
0.01% 853
2019
Q4
$4.35M Hold
760,000
0.01% 840
2019
Q3
$2.72M Hold
760,000
﹤0.01% 936
2019
Q2
$3.03M Hold
760,000
0.01% 904
2019
Q1
$5.56M Buy
760,000
+260,000
+52% +$2.54M 0.01% 749
2018
Q4
$4.58M Buy
+500,000
New +$5.53M 0.01% 765

Other funds holding DVAX

Macquarie Group's DVAX Position: Q4 2025 in Review

Macquarie Group sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 761,305 shares — an estimated $7.56M sold.

Macquarie Group first reported a position in DVAX in Q4 2018 and held it in 28 quarters. The position peaked at $14.7M in Q3 2021. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Macquarie Group reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 761,305 Dynavax Technologies shares in Q4 2025, an estimated $7.56M.
  • Macquarie Group first reported a position in Dynavax Technologies in Q4 2018 and held it in 28 quarters.
  • Macquarie Group's Dynavax Technologies position peaked at $14.7M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.